Skip to main content
Top
Published in: Neurological Sciences 3/2021

01-03-2021 | Multiple Sclerosis | Letter to the Editor

Takotsubo cardiomyopathy: an obscure cause of emerging cardiovascular manifestations in the setting of Bickerstaff’s brainstem encephalitis

Authors: Kenan Yalta, Ertan Yetkin, Tulin Yalta

Published in: Neurological Sciences | Issue 3/2021

Login to get access

Excerpt

Bickerstaff’s brainstem encephalitis (BBE) has been regarded as a specific form of post-infectious and potentially autoimmune neurological disorder with a relatively favorable prognosis and usually presents with sensorial changes, ophthalmoplegia, and ataxia [1, 2]. On the other hand, Takotsubo cardiomyopathy (TTC) has been renowned for its reversible nature and might be largely attributable to significant adrenergic discharge potentially associated with a variety of physical and emotional stressors [25]. In general, TTC generally presents with a variety of clinical signs including electrocardiographic (ECG) changes, specific myocardial wall motion abnormalities on transthoracic echocardiogram (TTE) (left ventricular apical ballooning), and elevation of myocardial enzymes (troponins) along with a wide range of symptoms including chest pain and dyspnea and hence strongly mimicks acute coronary syndromes (ACSs) and other acute heart failure syndromes [4]. Importantly, diagnosis of TTC requires new-onset wall motion abnormalities beyond the territory of a single coronary artery usually in the absence of culprit coronary lesions on coronary imaging [4]. Despite its widely recognized favorable outcome, it may occasionally be complicated by malignant arrhythmias and hemodynamic instability [4]. …
Literature
1.
go back to reference Kim HA, Lee H (2016) Generalized pan-autonomic failure as a presenting sign of Bickerstaff’s brainstem encephalitis. Neurol Sci 37(6):1001–1003CrossRef Kim HA, Lee H (2016) Generalized pan-autonomic failure as a presenting sign of Bickerstaff’s brainstem encephalitis. Neurol Sci 37(6):1001–1003CrossRef
3.
4.
go back to reference Yalta K, Yilmaztepe M, Zorkun C (2018) Left ventricular dysfunction in the setting of Takotsubo Cardiomyopathy: a review of clinical patterns and practical implications. Card Fail Rev 4(1):14–20CrossRef Yalta K, Yilmaztepe M, Zorkun C (2018) Left ventricular dysfunction in the setting of Takotsubo Cardiomyopathy: a review of clinical patterns and practical implications. Card Fail Rev 4(1):14–20CrossRef
6.
go back to reference Hussien NR, Al-Naimi MS, Rasheed HA et al (2018) Sulfonylurea and neuroprotection: the bright side of the moon. J Adv Pharm Technol Res 9(4):120–123CrossRef Hussien NR, Al-Naimi MS, Rasheed HA et al (2018) Sulfonylurea and neuroprotection: the bright side of the moon. J Adv Pharm Technol Res 9(4):120123CrossRef
7.
go back to reference Al-Kuraishy HM, Al-Gareeb AI, Naji MT, Al-Mamorry F (2020) Role of vinpocetine in ischemic stroke and poststroke outcomes: a critical review. Brain Circ 6(1):1–10CrossRef Al-Kuraishy HM, Al-Gareeb AI, Naji MT, Al-Mamorry F (2020) Role of vinpocetine in ischemic stroke and poststroke outcomes: a critical review. Brain Circ 6(1):1–10CrossRef
8.
go back to reference Al-Kuraishy HM, Al-Gareeb AI (2017) Central beneficial effects of trimetazidine on psychomotor performance in normal healthy volunteers. Adv Biomed Res 6:69CrossRef Al-Kuraishy HM, Al-Gareeb AI (2017) Central beneficial effects of trimetazidine on psychomotor performance in normal healthy volunteers. Adv Biomed Res 6:69CrossRef
9.
go back to reference Al-Kuraishy HM, Abdulhadi MH, Hussien NR et al (2020) Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review. Brain Circulation 6(2):70–80CrossRef Al-Kuraishy HM, Abdulhadi MH, Hussien NR et al (2020) Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review. Brain Circulation 6(2):70–80CrossRef
10.
go back to reference Saji N, Kawarai T, Tadano M, Shimizu H, Kita Y, Susuki K, Kanbayashi T (2007) Does CSF hypocretin-1 decrease in Bickerstaff’s brainstem encephalitis? Clin Neurol Neurosurg 109(6):547–548CrossRef Saji N, Kawarai T, Tadano M, Shimizu H, Kita Y, Susuki K, Kanbayashi T (2007) Does CSF hypocretin-1 decrease in Bickerstaff’s brainstem encephalitis? Clin Neurol Neurosurg 109(6):547–548CrossRef
Metadata
Title
Takotsubo cardiomyopathy: an obscure cause of emerging cardiovascular manifestations in the setting of Bickerstaff’s brainstem encephalitis
Authors
Kenan Yalta
Ertan Yetkin
Tulin Yalta
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 3/2021
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04749-z

Other articles of this Issue 3/2021

Neurological Sciences 3/2021 Go to the issue